Shelf Life Evaluation of Investigational Dosage Forms
Award Notice Posted
- Solicitation number
- N02CM37002_05
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Awarded
- to Mriglobal
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HHSN261201300007C Federal contract award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Not on record
- Place of performance
- Contractors facility - TBD, United States
Notice details come from SAM.gov. Updated .
Notice text
The Pharmaceutical Resources Branch (PRB), Developmental Therapeutics Program (DTP), Division of Cancer Treatment, and Diagnosis (DCTD), National Cancer Institute (NCI), is seeking a contractor to evaluate shelf life of samples of investigational clinical drug formulations. The products may include parenteral, oral, and other types of dosage forms. The results of such testing and evaluations will be provided promptly to the PRB. These reports will be used for:
- providing NCI and its investigators with information regarding the proper storage and handling of various drug products under investigation,
- determine continued conformance to the assigned specifications, and
- to support NCI's Investigational New Drug Applications (INDs) filed with the Food and Drug Administration (FDA).
Files
| File | Type | Posted |
|---|---|---|
| N02CM37002-05_Synopsis_posted_08232012.pdf | ||
| N02CM37002-05_Draft_SOW.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Shelf Life Evaluation of Investigational Dosage Forms | Award Notice | |
| This notice | Award Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity